Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GlyNAC for Chronic Postsurgical Pain Prevention in TKA
NCT06083480Phase 4Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Dec 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of glycine + n-acetylcysteine in chronic postsurgical pain (CPSP), sponsored by Vanderbilt University Medical Center. Started Dec 2024; status: recruiting.
02
Drugs
glycine + n-acetylcysteine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT06083480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06083480.